Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.2 has replaced v3.3.1 on the page; it is a minor version update and does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page's changelog. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe notice about potential government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedThe new screenshots show minor UI updates to the page header and layout without changes to trial details, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference5%

- Check68 days agoChange DetectedUpdated contact details and page revision from v3.0.2 to v3.1.0; added new phone numbers and email, with the old revision note removed.SummaryDifference0.1%

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.